ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?

ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?

The review presents recent data on the usage of platelet functional tests in patients with ischemic heart disease after percutaneous coronary intervention and its contribution to antiplatelet therapy personalization and cardiovascular events frequency reduction.

Saved in:

Bibliographic Details
Main Authors:	Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	platelet reactivity antiplatelet therapy percutaneous coronary intervention
Online Access:	https://www.rpcardio.online/jour/article/view/294
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

Molecular and metabolic characteristics of changes in the platelet sensitivity to antiplatelet therapy in patients with coronary artery disease before and after coronary artery bypass grafting
by: M. D. Goncharov, et al.
Published: (2021-07-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

ANTIPLATELET THERAPY OF ACUTE CORONARY SYNDROME: CURRENT CAPAB ILITIES
by: E. V. Konstantinova, et al.
Published: (2018-07-01)

THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY
by: D. A. Andreev
Published: (2015-09-01)

The impact of platelets and antiplatelets medications on immune mediation
by: Leela Morena, MD, et al.
Published: (2025-01-01)

Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period
by: T. P. Pronko, et al.
Published: (2025-01-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Phenotyping the Use of Cangrelor in Percutaneous Coronary Interventions
by: Nikolaos Pyrpyris, et al.
Published: (2025-03-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

Timing of dual antiplatelet therapy in acute coronary syndrome: a problem of coronary artery bypass grafting accessibility for patients
by: T. S. Golovina, et al.
Published: (2020-09-01)

ANTIPLATELET TREATMENT IN ST ELEVATION ACUTE CORONARY SYNDROME UNDER REAL CLINICAL CIRCUMSTANCES: THE DYNAMICS OF THROMBOCYTE FUNCTION
by: L. I. Malinova, et al.
Published: (2017-02-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Risk factors and outcomes of gastrointestinal bleeding in patients with stable coronary artery disease: data from the observational registry of long-term antithrombotic therapy REGATTA-1
by: A. L. Komarov, et al.
Published: (2021-07-01)

Antiplatelet therapy de-escalation in a patient after percutaneous coronary intervention with a high risk of bleeding
by: A. A. Kassymova, et al.
Published: (2023-06-01)

Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice
by: O. L. Barbarash, et al.
Published: (2018-11-01)

Treatment of Patients with Myocardial Infarction in Modern Conditions of a Regional Vascular Center
by: I. M. Kuzmina, et al.
Published: (2022-09-01)

Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome
by: I. Yu. Grinshtein, et al.
Published: (2016-11-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Consequences of escalation and de-escalation of double antiplatelet therapy in patients with acute coronary syndrome in real clinical practice
by: R. L. Shamraev, et al.
Published: (2019-04-01)

Double antiplatelet therapy in patients with acute coronary syndrome
by: A. V. Rodionov, et al.
Published: (2011-10-01)

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS
by: B. I. Kantemirova, et al.
Published: (2021-05-01)

Utilization and Outcomes of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement (TAVR)
by: Agam Bansal, et al.
Published: (2025-05-01)

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease
by: M. D. Goncharov, et al.
Published: (2021-03-01)

Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM
by: N. S. Kostritca, et al.
Published: (2024-07-01)

The study of price situation on the domestic antiplatelet market
by: Ye. А. Redkina, et al.
Published: (2017-08-01)

ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY
by: E. А. Ushkalova, et al.
Published: (2017-03-01)

WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. Yu. Gilyarov, et al.
Published: (2018-05-01)

High residual platelet aggregation in patients with coronary artery disease: a new methodological approach to detection
by: O. A. Trubacheva, et al.
Published: (2021-07-01)

MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: N. F. Puchinian, et al.
Published: (2017-03-01)

HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: O. O. Shakhmatova, et al.
Published: (2016-01-01)

Clinical case of retrograde endovascular recanalization of chronic coronary occlusion
by: D. K. Vasiliev, et al.
Published: (2019-11-01)

CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM
by: Yu. F. Salakhova, et al.
Published: (2016-01-01)

Factors influencing no-reflow phenomenon in patients with ST-segment myocardial infarction treated with primary percutaneous coronary intervention
by: Đenić Nemanja, et al.
Published: (2018-01-01)

Current trends of hybrid myocardial revascularization
by: Ya. A. Dyachenko, et al.
Published: (2023-03-01)

THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01)

ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: D. H. Ainetdinova, et al.
Published: (2016-01-01)